Faron Pharmaceuticals Oy Financial Flexibility Index
Faron Pharmaceuticals Oy financial flexibility index. Faron Pharmaceuticals Oy (FARN) has a Financial Flexibility Index of 0.00x as of June 2025. Free cash flow of GBX-5.21K (operating CF GBX-5.21K minus capex GBX0.00) represents 0% of total liabilities (GBX32.45 Million). See FARN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Faron Pharmaceuticals Oy (2012–2024)
Financial flexibility index of Faron Pharmaceuticals Oy from 2012 to 2024. Historical Financial Flexibility Index trend for Faron Pharmaceuticals Oy across 13 annual periods. Explore Faron Pharmaceuticals Oy (FARN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Faron Pharmaceuticals Oy Financial Flexibility Index by Year (2012–2024)
Faron Pharmaceuticals Oy financial flexibility index by year from 2012 to 2024. Year-by-year free cash flow to debt coverage for Faron Pharmaceuticals Oy. For the full cash flow conversion analysis, see cash efficiency ratio of Faron Pharmaceuticals Oy.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.02x | GBX-22.75 Million | GBX-22.97 Million | GBX22.28 Million | ▼ -9.4% |
| 2023 | -0.93x | GBX-23.68 Million | GBX-23.81 Million | GBX25.38 Million | ▲ +6.1% |
| 2022 | -0.99x | GBX-22.61 Million | GBX-22.99 Million | GBX22.75 Million | ▲ +53.1% |
| 2021 | -2.12x | GBX-21.74 Million | GBX-22.22 Million | GBX10.26 Million | ▼ -24.8% |
| 2020 | -1.70x | GBX-17.34 Million | GBX-17.48 Million | GBX10.22 Million | ▼ -27.7% |
| 2019 | -1.33x | GBX-11.42 Million | GBX-11.52 Million | GBX8.60 Million | ▼ -49306.8% |
| 2018 | 0.00x | GBX-20.52K | GBX-20.52K | GBX7.63 Million | ▲ +99.9% |
| 2017 | -1.80x | GBX-18.27 Million | GBX-18.36 Million | GBX10.14 Million | ▼ -37.9% |
| 2016 | -1.31x | GBX-8.36 Million | GBX-8.45 Million | GBX6.40 Million | ▲ +32.4% |
| 2015 | -1.93x | GBX-7.04 Million | GBX-7.15 Million | GBX3.64 Million | ▼ -2622.1% |
| 2014 | -0.07x | GBX-238.00K | GBX-389.00K | GBX3.35 Million | ▲ +67.5% |
| 2013 | -0.22x | GBX-695.00K | GBX-768.00K | GBX3.19 Million | ▲ +63.3% |
| 2012 | -0.60x | GBX-1.65 Million | GBX-2.27 Million | GBX2.77 Million | — |